Skip to main content
Clinical Trials/CTRI/2022/11/047129
CTRI/2022/11/047129
Not yet recruiting
Phase 4

Double blinded randomized Controlled Study Comparing the Efficacy and Tolerance of levocetrizine, Bilastine and Bepotastine in Patients with Urticaria.

Meenakshi medical college hospital and research institute0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Meenakshi medical college hospital and research institute
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Pms

Investigators

Sponsor
Meenakshi medical college hospital and research institute

Eligibility Criteria

Inclusion Criteria

  • 1\)Patients with diagnosis of urticaria (acute/chronic)
  • 2\)Patients for whom documented consent has been obtained regarding their voluntary participation in this clinical study
  • 3\) Patients aged 18 years or older at the time that they provide consent.
  • 4\) Patient agrees not to take other treatments than those provided in the study.

Exclusion Criteria

  • 1\)pregnant and lactating females
  • 2\)patients who are immunocompromised due to disease or drugs
  • 3\) Patients with pruritis caused due to other cutaneous skin disorders.
  • 4\) Patients with known hypersensitivity to antihistamines.
  • 5\) Known case of Bronchial asthama / COPD.
  • 6\) Patients with urticaria presenting with systemic signs/symptoms
  • 7\) Patients with urticaria and angio oedema

Outcomes

Primary Outcomes

Not specified

Similar Trials